BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 201086)

  • 1. Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.
    Katsuki T; Hinuma Y; Yamamoto N; Abo T; Kumagai K
    Virology; 1977 Dec; 83(2):287-94. PubMed ID: 201086
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV), lymphocytes and transformation.
    Zeuthen J
    J Cancer Res Clin Oncol; 1983; 106(1):1-11. PubMed ID: 6309856
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.
    Einhorn L; Steinitz M; Yefenof E; Ernberg I; Bakacs T; Klein G
    Cell Immunol; 1978 Jan; 35(1):43-58. PubMed ID: 202404
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus strategy in normal and neoplastic B cells.
    Klein G
    Cell; 1994 Jun; 77(6):791-3. PubMed ID: 8004668
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation.
    Moss DJ; Rickinson AB; Wallace LE; Epstein MA
    Nature; 1981 Jun; 291(5817):664-6. PubMed ID: 6264317
    [No Abstract]   [Full Text] [Related]  

  • 6. The B cell-immortalizing functions of Epstein-Barr virus.
    Ring CJ
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():1-13. PubMed ID: 8113717
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of measles and Epstein-Barr viruses in transformed human lymphocytes.
    Jankowski M; Sadowski W
    Acta Microbiol Pol; 1982; 31(1):15-21. PubMed ID: 6184957
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus and T-cell lymphoma.
    Lancet; 1988 Sep; 2(8613):723-4. PubMed ID: 2901575
    [No Abstract]   [Full Text] [Related]  

  • 9. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of Epstein-Barr virus susceptibility in human tonsil B lymphocyte subpopulations].
    Harabuchi Y; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1799-811. PubMed ID: 2833594
    [No Abstract]   [Full Text] [Related]  

  • 11. Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes.
    Steel CM; Philipson J; Arthur E; Gardiner SE; Newton MS; McIntosh RV
    Nature; 1977 Dec 22-29; 270(5639):729-31. PubMed ID: 201868
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucocorticoid receptors in Epstein-Barr virus-transformed human lymphocytes.
    Tomita M; Chrousos GP; Brandon DD; Ben-Or S; Foster CM; De Vougn L; Taylor S; Loriaux DL; Lipsett MB
    Horm Metab Res; 1985 Dec; 17(12):674-8. PubMed ID: 3002935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of phospholipase-D in Epstein Barr virus-transformed human B-cells.
    Foster KA; Gibb BA; Storch J
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):291S. PubMed ID: 8224439
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.
    Hutt-Fletcher L
    Springer Semin Immunopathol; 1991; 13(2):117-31. PubMed ID: 1664981
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-phosphorylcholine antibody-producing cells in human lymphoblastoid cell lines established by transformation with Epstein-Barr virus.
    Yoshie O; Ono Y
    Cell Immunol; 1980 Dec; 56(2):305-16. PubMed ID: 6258807
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation in the presence of dimethyl sulfoxide facilitates recovery of Epstein-Barr virus.
    Wilson GL
    Intervirology; 1983; 19(1):56-60. PubMed ID: 6298146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
    Henderson EE; Yang JY; Zhang RD; Bealer M
    Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.